IntechOpen

Home > Authors and editors

Arli Aditya ParikesitORCID icon for 0000-0001-8716-3926

Indonesia International Institute for Life Sciences Indonesia

Prof. Dr. rer. nat. Arli Aditya Parikesit is a distinguished Indonesian bioinformatician and Professor of Bioinformatics at the i3L University (formerly Indonesia International Institute for Life Sciences) in Jakarta, Indonesia. He has dedicated his career to advancing computational biology, with research interests spanning structural bioinformatics, immunoinformatics, rational drug and vaccine design, and the integration of artificial intelligence (AI) in molecular simulations. Prof. Parikesit completed his undergraduate and Master’s studies in Chemistry and Biotechnology at the University of Indonesia. Supported by a DAAD (German Academic Exchange Service) fellowship, he earned his Ph.D. (Dr. rer. nat.) in Bioinformatics from the University of Leipzig, Germany, where his doctoral research focused on advanced protein domain annotation across the three domains of life. Throughout his career, Prof. Parikesit has held several key academic and leadership roles at i3L University, serving as the Head of the Bioinformatics Department (2016-2021) and the Vice-Rector for Research and Innovation (2021-2024). Up to now, Prof Parikesit still serves as an academic senate member. A highly active voice in the global scientific community, he has published over 150 peer-reviewed papers in international journals and conference proceedings. His current research leverages machine learning, transcriptomics, and computational pipelines to design modern diagnostics and RNA-based therapeutics. He is a member of the Indonesian Society for Bioinformatics and Biodiversity (MABBI) and an honorary member of the Indonesian Young Academy of Science (ALMI), dedicated to bridging academic innovation, industrial application, and public health policy.

Arli Aditya Parikesit

Links

Personal website

7books edited

7chapters authored

Latest work with IntechOpen by Arli Aditya Parikesit

With the continued threat of viral pandemics and the emergence of pathogens that resist current therapeutic agents, there is now, more than ever, a greater need to develop rationally designed antiviral agents. This book provides a scientific but easy-to-understand overview of various aspects of modern-day antiviral drug design. Readers will gain insight into broad-spectrum antiviral drug design for respiratory viruses such as SARS-CoV-2 and influenza A, as well as discussions of direct-acting antiviral drugs, high-throughput bioassay development, and molecular docking of natural products as novel antivirals. Other aspects discussed in this volume include the results of antiretroviral therapy, resistance and drug-sensitivity testing, and ethnoveterinary antiviral drug screening methods. One major strength of this book is its blend of computational and experimental approaches to the antiviral drug design problem. With these aspects covered in great detail, this book makes for an excellent reference guide for anyone interested in antiviral drug design research. This book will also serve as an excellent teaching aid for postgraduate studies on antiviral drugs and their structure-based drug design. As an open-access volume, the book will be valuable to researchers worldwide.

Go to the book
Antiviral Drugs IntechOpen
Antiviral Drugs The Rational Design of Antiviral Agents Edited by Arli Aditya Parikesit

Antiviral Drugs - The Rational Design of Antiviral Agents

Edited by Arli Aditya Parikesit

Books edited

Related collaborators

Your cart

Discounts available on purchase of multiple copies. View rates

Subtotal €0.00

Local taxes (VAT) are calculated in later steps, if applicable.

Support: orders@intechopen.com